It has been demonstrated that RASA1 stimulates the GTPase activity of normal RAS p21 and that the aberrant downregulation of RASA1 leads to abnormal cellular growth and proliferation, via the downstream RAS-MAPK signaling pathway, which has anti-apoptotic and pro-survival effects in numerous types of cancer (22,34). The gene discussed is RASA1; the disease is cancer.